HCW Biologics Inc. is trading 7% down today at $1.45 after the company filed to register the resale of up to 5.7 million shares by selling stockholders.
- The filing, which was made on June 8, 2026, relates to shares from a private placement that occurred in May 2026.
- The company will not receive any proceeds from the sale of these shares.
- This potential for a large number of shares to enter the market is a likely catalyst for the stock's continued decline, which has seen it fall from $2.07 on June 1.